FLT3 inhibitors trigger ferroptosis, exposing new weakness in acute myeloid leukemia

FLT3 inhibitors trigger ferroptosis, exposing new weakness in acute myeloid leukemia

A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might lead to novel therapies to treat the cancer while minimizing harm to normal cells. Researchers at Baylor College of Medicine and collaborating institutions studied a new mechanism by which drugs that neutralize FLT3 mutations work.

If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.

If you want to read more Like this articles, you can visit our Science category.

Source

Leave a Reply

Your email address will not be published. Required fields are marked *